Is it safe to stop oral anticoagulation after catheter ablation for atrial fibrillation?

References

• Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat Rev Cardiol. 2014 Nov;11(11):639–654. PubMed PMID: 25113750.
   PubMed Web of Science ®Google Scholar
• Pistoia F, Sacco S, Tiseo C, et al. The epidemiology of atrial fibrillation and stroke. Cardiol Clin. 2016 May;34(2):255–268. PubMed PMID: 27150174.
   PubMed Web of Science ®Google Scholar
• Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA. 2001 May 9;285(18):2370–2375. PubMed PMID: 11343485.
   PubMed Web of Science ®Google Scholar
• Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006 Jul 11;114(2):119–125. PubMed PMID: 16818816.
   PubMed Web of Science ®Google Scholar
• Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014 Feb 25;129(8):837–847. PubMed PMID: 24345399; PubMed Central PMCID: PMCPMC4151302.
   PubMed Web of Science ®Google Scholar
• Writing Group M, Mozaffarian D, Benjamin EJ, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016 Jan 26;133(4):e38–e360. PubMed PMID: 26673558.
   PubMed Web of Science ®Google Scholar
• Stefansdottir H, Aspelund T, Gudnason V, et al. Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. Europace. 2011 Aug;13(8):1110–1117. PubMed PMID: 21551478.
   PubMed Web of Science ®Google Scholar
• Colilla S, Crow A, Petkun W, et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol. 2013 Oct 15;112(8):1142–1147. PubMed PMID: 23831166.
   PubMed Web of Science ®Google Scholar
• Moran A, Forouzanfar M, Sampson U, et al. The epidemiology of cardiovascular diseases in sub-Saharan Africa: the global burden of diseases, injuries and risk factors 2010 study. Prog Cardiovasc Dis. 2013 Nov-Dec;56(3):234–239. PubMed PMID: 24267430; PubMed Central PMCID: PMCPMC4031901.
   PubMed Web of Science ®Google Scholar
• Bruggenjurgen B, Rossnagel K, Roll S, et al. The impact of atrial fibrillation on the cost of stroke: the berlin acute stroke study. Value Health. 2007 Mar-Apr;10(2):137–143. PubMed PMID: 17391422.
   PubMed Web of Science ®Google Scholar
• Blomstrom Lundqvist C, Lip GY, Kirchhof P. What are the costs of atrial fibrillation? Europace. 2011 May;13(Suppl 2):ii9–ii12. PubMed PMID: 21518753.
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Rev Esp Cardiol (Engl Ed). 2017 Jan;70(1):50. PubMed PMID: 28038729.
   PubMed Web of Science ®Google Scholar
• Bjorck S, Palaszewski B, Friberg L, et al. Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study. Stroke. 2013 Nov;44(11):3103–3108. PubMed PMID: 23982711.
   PubMed Web of Science ®Google Scholar
• Friberg L, Tabrizi F, Englund A. Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries. Eur Heart J. 2016 Aug;37(31):2478–2487. PubMed PMID: 26984861.
   PubMed Web of Science ®Google Scholar
• Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. Lancet. 2009 Jan 10;373(9658):155–166. PubMed PMID: 19135613.
   PubMed Web of Science ®Google Scholar
• Akar JG, Jeske W, Wilber DJ. Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction. J Am Coll Cardiol. 2008 May 6;51(18):1790–1793. PubMed PMID: 18452786.
   PubMed Web of Science ®Google Scholar
• Lim HS, Willoughby SR, Schultz C, et al. Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. J Am Coll Cardiol. 2013 Feb 26;61(8):852–860. PubMed PMID: 23333141.
   PubMed Web of Science ®Google Scholar
• Sohara H, Amitani S, Kurose M, et al. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol. 1997 Jan;29(1):106–112. PubMed PMID: 8996302.
   PubMed Web of Science ®Google Scholar
• Lip GY, Lip PL, Zarifis J, et al. Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. Circulation. 1996 Aug 1;94(3):425–431. PubMed PMID: 8759084.
   PubMed Web of Science ®Google Scholar
• Wang TD, Chen WJ, Su SS, et al. Increased levels of tissue plasminogen activator antigen and factor VIII activity in nonvalvular atrial fibrillation: relation to predictors of thromboembolism. J Cardiovasc Electrophysiol. 2001 Aug;12(8):877–884. PubMed PMID: 11523531.
   PubMed Web of Science ®Google Scholar
• Spronk HM, De Jong AM, Verheule S, et al. Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation. Eur Heart J. 2017 Jan 1;38(1):38–50. PubMed PMID: 27071821.
   PubMed Web of Science ®Google Scholar
• Atalar E, Haznedaroglu IC, Acil T, et al. Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia. Platelets. 2003 Nov-Dec;14(7–8):407–411. PubMed PMID: 14713509.
   PubMed Web of Science ®Google Scholar
• Borissoff JI, Spronk HM, Ten Cate H. The hemostatic system as a modulator of atherosclerosis. N Engl J Med. 2011 May 5;364(18):1746–1760. PubMed PMID: 21542745.
   PubMed Web of Science ®Google Scholar
• Macfarlane SR, Seatter MJ, Kanke T, et al. Proteinase-activated receptors. Pharmacol Rev. 2001 Jun;53(2):245–282. PubMed PMID: 11356985.
   PubMed Web of Science ®Google Scholar
• Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997 Aug 19;96(4):1180–1184. PubMed PMID: 9286947.
   PubMed Web of Science ®Google Scholar
• Inoue H, Nozawa T, Okumura K, et al. Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism. Chest. 2004 Sep;126(3):687–692. PubMed PMID: 15364743.
   PubMed Web of Science ®Google Scholar
• Conway DS, Buggins P, Hughes E, et al. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol. 2004 Jun 2;43(11):2075–2082. PubMed PMID: 15172416.
   PubMed Web of Science ®Google Scholar
• Takada T, Yasaka M, Nagatsuka K, et al. Blood flow in the left atrial appendage and embolic stroke in nonvalvular atrial fibrillation. Eur Neurol. 2001;46(3):148–152. PubMed PMID: 11598333.
   PubMed Web of Science ®Google Scholar
• Delgado V, Di Biase L, Leung M, et al. Structure and function of the left atrium and left atrial appendage: AF and stroke implications. J Am Coll Cardiol. 2017 Dec 26;70(25):3157–3172. PubMed PMID: 29268928.
   PubMed Web of Science ®Google Scholar
• Manning WJ, Silverman DI, Katz SE, et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol. 1994 Jun;23(7):1535–1540. PubMed PMID: 8195510.
   PubMed Web of Science ®Google Scholar
• Dell’Era G, Rondano E, Franchi E, et al. Atrial asynchrony and function before and after electrical cardioversion for persistent atrial fibrillation. Eur J Echocardiogr. 2010 Aug;11(7):577–583. PubMed PMID: 20400765.
   PubMed Web of Science ®Google Scholar
• Bax JJ, Marsan NA, Delgado V. Non-invasive imaging in atrial fibrillation: focus on prognosis and catheter ablation. Heart. 2015 Jan;101(2):94–100. PubMed PMID: 25412729.
   PubMed Web of Science ®Google Scholar
• Atrial Fibrillation Investigators. Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. Arch Intern Med. 1998 Jun 22;158(12):1316–1320. PubMed PMID: 9645825.
   PubMed Web of Science ®Google Scholar
• Di Biase L, Santangeli P, Anselmino M, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol. 2012 Aug 7;60(6):531–538. PubMed PMID: 22858289.
   PubMed Web of Science ®Google Scholar
• Zabalgoitia M, Halperin JL, Pearce LA, et al. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke prevention in atrial fibrillation III investigators. J Am Coll Cardiol. 1998 Jun;31(7):1622–1626. PubMed PMID: 9626843.
   PubMed Web of Science ®Google Scholar
• Lupercio F, Carlos Ruiz J, Briceno DF, et al. Left atrial appendage morphology assessment for risk stratification of embolic stroke in patients with atrial fibrillation: a meta-analysis. Heart Rhythm. 2016 Jul;13(7):1402–1409. PubMed PMID: 27016474.
   PubMed Web of Science ®Google Scholar
• Donal E, Ollivier R, Veillard D, et al. Left atrial function assessed by trans-thoracic echocardiography in patients treated by ablation for a lone paroxysmal atrial fibrillation. Eur J Echocardiogr. 2010 Dec;11(10):845–852. PubMed PMID: 20858660.
   PubMed Web of Science ®Google Scholar
• Ciuffo L, Inoue YY, Tao S, et al. Mechanical dyssynchrony of the left atrium during sinus rhythm is associated with history of stroke in patients with atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2018 Apr 1;19(4):433–441. PubMed PMID: 29579200.
   PubMed Web of Science ®Google Scholar
• Calkins H, Hindricks G, Cappato R, et al. HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2017 Oct;14(10):e275–e444. PubMed PMID: 28506916.
   PubMed Web of Science ®Google Scholar
• Liang JJ, Dixit S, Santangeli P. Mechanisms and clinical significance of early recurrences of atrial arrhythmias after catheter ablation for atrial fibrillation. World J Cardiol. 2016 Nov 26;8(11):638–646. PubMed PMID: 27957250; PubMed Central PMCID: PMCPMC5124722.
   PubMed Web of Science ®Google Scholar
• Andrade JG, Khairy P, Verma A, et al. Early recurrence of atrial tachyarrhythmias following radiofrequency catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2012 Jan;35(1):106–116. PubMed PMID: 22054110.
   PubMed Web of Science ®Google Scholar
• Takigawa M, Takahashi A, Kuwahara T, et al. Long-term follow-up after catheter ablation of paroxysmal atrial fibrillation: the incidence of recurrence and progression of atrial fibrillation. Circ Arrhythm Electrophysiol. 2014 Apr;7(2):267–273. PubMed PMID: 24610740.
   PubMed Web of Science ®Google Scholar
• Verma A, Champagne J, Sapp J, et al. Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study. JAMA Intern Med. 2013 Jan 28;173(2):149–156. PubMed PMID: 23266597.
   PubMed Web of Science ®Google Scholar
• Daoud EG, Glotzer TV, Wyse DG, et al. Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS. Heart Rhythm. 2011 Sep;8(9):1416–1423. PubMed PMID: 21699833.
   PubMed Web of Science ®Google Scholar
• Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014 Jun 26;370(26):2478–2486. PubMed PMID: 24963567.
   PubMed Web of Science ®Google Scholar
• Gladstone DJ, Spring M, Dorian P, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014 Jun 26;370(26):2467–2477. PubMed PMID: 24963566.
   PubMed Web of Science ®Google Scholar
• Page RL, Wilkinson WE, Clair WK, et al. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation. 1994 Jan;89(1):224–227. PubMed PMID: 8281651.
   PubMed Web of Science ®Google Scholar
• Savelieva I, Camm AJ. Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J Interv Card Electrophysiol. 2000 Jun;4(2):369–382. PubMed PMID: 10936003.
   PubMed Web of Science ®Google Scholar
• Rho RW, Page RL. Asymptomatic atrial fibrillation. Prog Cardiovasc Dis. 2005 Sep-Oct;48(2):79–87. PubMed PMID: 16253649.
   PubMed Web of Science ®Google Scholar
• Hindricks G, Piorkowski C, Tanner H, et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation. 2005 Jul 19;112(3):307–313. PubMed PMID: 16009793.
   PubMed Web of Science ®Google Scholar
• Pappone C, Santinelli V, Manguso F, et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation. 2004 Jan 27;109(3):327–334. PubMed PMID: 14707026.
   PubMed Web of Science ®Google Scholar
• Tsai CF, Chen SA, Tai CT, et al. Bezold-Jarisch-like reflex during radiofrequency ablation of the pulmonary vein tissues in patients with paroxysmal focal atrial fibrillation. J Cardiovasc Electrophysiol. 1999 Jan;10(1):27–35. PubMed PMID: 9930906.
   PubMed Web of Science ®Google Scholar
• Nilsson B, Chen X, Pehrson S, et al. Increased resting heart rate following radiofrequency catheter ablation for atrial fibrillation. Europace. 2005 Sep;7(5):415–420. PubMed PMID: 16087103.
   PubMed Web of Science ®Google Scholar
• Hamdan MH, Page RL, Wasmund SL, et al. Selective parasympathetic denervation following posteroseptal ablation for either atrioventricular nodal reentrant tachycardia or accessory pathways. Am J Cardiol. 2000 Apr 1;85(7):875–8, A9. PubMed PMID: 10758931.
   PubMed Web of Science ®Google Scholar
• Chiou CW, Zipes DP. Selective vagal denervation of the atria eliminates heart rate variability and baroreflex sensitivity while preserving ventricular innervation. Circulation. 1998 Jul 28;98(4):360–368. PubMed PMID: 9711942.
   PubMed Web of Science ®Google Scholar
• Wokhlu A, Monahan KH, Hodge DO, et al. Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect. J Am Coll Cardiol. 2010 May 25;55(21):2308–2316. PubMed PMID: 20488300.
   PubMed Web of Science ®Google Scholar
• Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011 Sep 15;365(11):981–992. PubMed PMID: 21870978.
   PubMed Web of Science ®Google Scholar
• Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013 Nov 28;369(22):2093–2104. PubMed PMID: 24251359.
   PubMed Web of Science ®Google Scholar
• Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009 Sep 17;361(12):1139–1151. PubMed PMID: 19717844.
   PubMed Web of Science ®Google Scholar
• Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011 Sep 8;365(10):883–891. PubMed PMID: 21830957.
   PubMed Web of Science ®Google Scholar
• Bunch TJ, Crandall BG, Weiss JP, et al. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol. 2011 Aug;22(8):839–845. PubMed PMID: 21410581.
   PubMed Web of Science ®Google Scholar
• Themistoclakis S, Corrado A, Marchlinski FE, et al. The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. J Am Coll Cardiol. 2010 Feb 23;55(8):735–743. PubMed PMID: 20170810.
   PubMed Web of Science ®Google Scholar
• Karasoy D, Gislason GH, Hansen J, et al. Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark. Eur Heart J. 2015 Feb 1;36(5):307–14a. PubMed PMID: 25368205.
   PubMed Web of Science ®Google Scholar
• Nademanee K, Schwab MC, Kosar EM, et al. Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation. J Am Coll Cardiol. 2008 Feb 26;51(8):843–849. PubMed PMID: 18294570.
   PubMed Web of Science ®Google Scholar
• Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015 May 7;372(19):1812–1822. PubMed PMID: 25946280.
   PubMed Web of Science ®Google Scholar
• Winkle RA, Mead RH, Engel G, et al. Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes. J Interv Card Electrophysiol. 2013 Dec;38(3):147–153. PubMed PMID: 24101149; PubMed Central PMCID: PMCPMC3825152.
   PubMed Web of Science ®Google Scholar
• Saad EB, d’Avila A, Costa IP, et al. Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score </=3: a long-term outcome study. Circ Arrhythm Electrophysiol. 2011 Oct;4(5):615–621. PubMed PMID: 21841192.
   PubMed Web of Science ®Google Scholar
• Riley MP, Zado E, Hutchinson MD, et al. Risk of stroke or transient ischemic attack after atrial fibrillation ablation with oral anticoagulant use guided by ECG monitoring and pulse assessment. J Cardiovasc Electrophysiol. 2014 Jun;25(6):591–596. PubMed PMID: 24533561.
   PubMed Web of Science ®Google Scholar
• Liang JJ, Elafros MA, Mullen MT, et al. Anticoagulation use and clinical outcomes after catheter ablation in patients with persistent and longstanding persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2018 Jan 24;18(1):24. PubMed PMID: 29368639; PubMed Central PMCID: PMCPMC5784503.
   Google Scholar
• Go AS, Reynolds K, Yang J, et al. Association of burden of atrial fibrillation with risk of ischemic stroke in adults with paroxysmal atrial fibrillation: the KP-RHYTHM study. JAMA Cardiol. 2018 Jul 1;3(7):601–608. PubMed PMID: 29799942.
   PubMed Web of Science ®Google Scholar
• Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998 Sep 3;339(10):659–666. PubMed PMID: 9725923.
   PubMed Web of Science ®Google Scholar
• Kuck KH, Brugada J, Furnkranz A, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016 Jun 9;374(23):2235–2245. PubMed PMID: 27042964.
   PubMed Web of Science ®Google Scholar
• Romero J, Michaud GF, Avendano R, et al. Benefit of left atrial appendage electrical isolation for persistent and long-standing persistent atrial fibrillation: a systematic review and meta-analysis. Europace. 2018 Jan 12. PubMed PMID: 29342299. DOI:10.1093/europace/eux372
   Web of Science ®Google Scholar
• Romero J, Natale A, Di Biase L. Left atrial appendage empirical electrical isolation for persistent atrial fibrillation: time for a change in practice. Europace. 2017 May 1;19(5):699–702. PubMed PMID: 28402461.
   PubMed Web of Science ®Google Scholar
• Baczek VL, Chen WT, Kluger J, et al. Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis. BMC Fam Pract. 2012 Feb 3;13:5. PubMed PMID: 22304704; PubMed Central PMCID: PMCPMC3395868.
   PubMed Web of Science ®Google Scholar
• Sudlow M, Thomson R, Thwaites B, et al. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet. 1998 Oct 10;352(9135):1167–1171. S0140-6736(98)01401-9 [pii] 10.1016/S0140-6736(98)01401-9. PubMed PMID: 9777832; eng.
   PubMed Web of Science ®Google Scholar
• Kwong JS, Lam YY, Yan BP, et al. Bleeding of new oral anticoagulants for stroke prevention in atrial fibrillation: a meta-analysis of randomized controlled trials. Cardiovasc Drugs Ther. 2013 Feb;27(1):23–35. PubMed PMID: 23224686; eng.
   PubMed Web of Science ®Google Scholar
• Dhanunjaya Lakkireddy M, Mahankali AS, Kanmanthareddy A, et al. Left atrial appendage ligation and ablation for persistent atrial fibrillation the LAALA-AF registry. J Am Coll Cardiol EP. 2015;1:153–160. PubMed PMID: 28167088.
   Google Scholar
• Panikker S, Jarman JW, Virmani R, et al. Left atrial appendage electrical isolation and concomitant device occlusion to treat persistent atrial fibrillation: a first-in-human safety, feasibility, and efficacy study. Circ Arrhythm Electrophysiol. 2016 Jul;9(7). PubMed PMID: 27406602. DOI:10.1161/CIRCEP.115.003710
   Web of Science ®Google Scholar
• Fassini G, Conti S, Moltrasio M, et al. Concomitant cryoballoon ablation and percutaneous closure of left atrial appendage in patients with atrial fibrillation. Europace. 2016 Nov;18(11):1705–1710. PubMed PMID: 27402623.
   PubMed Web of Science ®Google Scholar
• Kimmel SE, Chen Z, Price M, et al. The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study. Arch Internal Med. 2007 Feb 12;167(3):229–235. PubMed PMID: 17296877.
   PubMed Web of Science ®Google Scholar
• Laliberte F, Cloutier M, Nelson WW, et al. Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients. Curr Med Res Opin. 2014 Jul;30(7):1317–1325. PubMed PMID: 24650301.
   PubMed Web of Science ®Google Scholar
• Shehab A, Bhagavathula AS, Abebe TB, et al. Patient adherence to Novel Oral Anticoagulants (NOACs) for the treatment of atrial fibrillation and occurrence of associated bleeding events: a systematic review and meta-analysis. Curr Vasc Pharmacol. 2018 Jan 22. PubMed PMID: 29359674. DOI:10.2174/1570161116666180123111949
   Google Scholar
• Amin A, Bruno A, Trocio J, et al. Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US. J Med Econ. 2015 Jun;18(6):399–409. PubMed PMID: 25586203.
   PubMed Web of Science ®Google Scholar
• Deitelzweig S, Amin A, Jing Y, et al. Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trials. J Med Econ. 2012;15(4):776–785. PubMed PMID: 22449118.
   PubMedGoogle Scholar
• Reddy VY, Akehurst RL, Armstrong SO, et al. Time to cost-effectiveness following stroke reduction strategies in AF: Warfarin versus NOACs versus LAA closure. J Am Coll Cardiol. 2015 Dec 22;66(24):2728–2739. PubMed PMID: 26616031.
   PubMed Web of Science ®Google Scholar
• Hakalahti A, Biancari F, Nielsen JC, et al. Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis. Europace. 2015 Mar;17(3):370–378. PubMed PMID: 25643988.
   PubMed Web of Science ®Google Scholar
• Nielsen JC, Johannessen A, Raatikainen P, et al. Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial. Heart. 2017 Mar;103(5):368–376. PubMed PMID: 27566295.
   PubMed Web of Science ®Google Scholar
• Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012 Jan 12;366(2):120–129. PubMed PMID: 22236222.
   PubMed Web of Science ®Google Scholar
• Larsen BS, Kumarathurai P, Falkenberg J, et al. Excessive atrial ectopy and short atrial runs increase the risk of stroke beyond incident atrial fibrillation. J Am Coll Cardiol. 2015 Jul 21;66(3):232–241. PubMed PMID: 26184616.
   PubMed Web of Science ®Google Scholar
• Berger M, Schweitzer P. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis. Am J Cardiol. 1998 Dec 15;82(12):1545–7, A8. PubMed PMID: 9874066.
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the heart rhythm society. J Am Coll Cardiol. 2014 Dec 2;64(21):e1–e76. PubMed PMID: 24685669.
   PubMed Web of Science ®Google Scholar
• Moreyra E, Finkelhor RS, Cebul RD. Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: an analysis of pooled trials. Am Heart J. 1995 Jan;129(1):71–75. PubMed PMID: 7817928.
   PubMed Web of Science ®Google Scholar
• Gallagher MM, Hennessy BJ, Edvardsson N, et al. Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion. J Am Coll Cardiol. 2002 Sep 4;40(5):926–933. PubMed PMID: 12225717.
   PubMed Web of Science ®Google Scholar
• Jaber WA, Prior DL, Thamilarasan M, et al. Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: A transesophageal echocardiographic study. Am Heart J. 2000 Jul;140(1):150–156. PubMed PMID: 10874278.
   PubMed Web of Science ®Google Scholar
• You JJ, Singer DE, Howard PA, et al. Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e531S–e575S. PubMed PMID: 22315271; PubMed Central PMCID: PMCPMC3278056.
   PubMed Web of Science ®Google Scholar
• Weigner MJ, Caulfield TA, Danias PG, et al. Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours. Ann Intern Med. 1997 Apr 15;126(8):615–620. PubMed PMID: 9103128.
   PubMed Web of Science ®Google Scholar
• Kleemann T, Becker T, Strauss M, et al. Prevalence of left atrial thrombus and dense spontaneous echo contrast in patients with short-term atrial fibrillation &lt; 48 hours undergoing cardioversion: value of transesophageal echocardiography to guide cardioversion. J Am Soc Echocardiogr. 2009 Dec;22(12):1403–1408. PubMed PMID: 19880280.
   PubMed Web of Science ®Google Scholar